Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - BMJ open, 2023 - bmjopen.bmj.com
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - BMJ Open, 2023 - europepmc.org
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
[PDF][PDF] Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - oneamyloidosisvoice.com
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …
Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare …
L Obici, R Callaghan, J Ablett, C Bibiloni… - BMJ …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
[HTML][HTML] Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - BMJ Open, 2023 - ncbi.nlm.nih.gov
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
[PDF][PDF] Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - aan.org.au
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …
Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - BMJ …, 2023 - search.proquest.com
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
potentially life-limiting multisystem disease, affecting every aspect of a patient's life …
[引用][C] Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary …
L Obici, R Callaghan, J Ablett, C Bibiloni, T Bueser… - europepmc.org
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …
potentially lifelimiting multisystem disease, affecting every aspect of a patient's life …